Detalhe da pesquisa
1.
Computed tomography-based 3D convolutional neural network deep learning model for predicting micropapillary or solid growth pattern of invasive lung adenocarcinoma.
Radiol Med
; 129(5): 776-784, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38512613
2.
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 23(6): 739-747, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35576956
3.
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer: The ASTRUM-005 Randomized Clinical Trial.
JAMA
; 328(12): 1223-1232, 2022 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36166026
4.
Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma: The ESCORT-1st Randomized Clinical Trial.
JAMA
; 326(10): 916-925, 2021 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34519801
5.
Diagnostic Value of Video-assisted Mediastinoscopy and Endobronchial Ultrasound-guided Transbronchial Needle Aspiration for Mediastinal Lymphadenectasis without Pulmonary Abnormalities.
Med Sci Monit
; 23: 3064-3070, 2017 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28642455
6.
Myeloprotection with trilaciclib in Chinese patients with extensive-stage small cell lung cancer receiving chemotherapy: Results from a randomized, double-blind, placebo-controlled phase III study (TRACES).
Lung Cancer
; 188: 107455, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38224653
7.
Gumarontinib in patients with non-small-cell lung cancer harbouring MET exon 14 skipping mutations: a multicentre, single-arm, open-label, phase 1b/2 trial.
EClinicalMedicine
; 59: 101952, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37096188
8.
Efficacy, safety and pharmacokinetics of Unecritinib (TQ-B3101) for patients with ROS1 positive advanced non-small cell lung cancer: a Phase I/II Trial.
Signal Transduct Target Ther
; 8(1): 249, 2023 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37385995
9.
AIR-Net: A novel multi-task learning method with auxiliary image reconstruction for predicting EGFR mutation status on CT images of NSCLC patients.
Comput Biol Med
; 141: 105157, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34953355
10.
Reconstruction-Assisted Feature Encoding Network for Histologic Subtype Classification of Non-Small Cell Lung Cancer.
IEEE J Biomed Health Inform
; 26(9): 4563-4574, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35849680
11.
A CT-based nomogram for predicting the risk of adenocarcinomas in patients with subsolid nodule according to the 2021 WHO classification.
Cancer Imaging
; 22(1): 46, 2022 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36064495
12.
Urban-Rural Differences in Clinical Characteristics of Prostate Cancer at Initial Diagnosis: A Single-Center Observational Study in Anhui Province, China.
Front Oncol
; 11: 704645, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34414112
13.
Association between p73 G4C14-to-A4T14 polymorphism and lung cancer risk: A systematic review and meta-analysis.
Clin Respir J
; 15(6): 637-647, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33484055
14.
Apatinib Plus Gefitinib as First-Line Treatment in Advanced EGFR-Mutant NSCLC: The Phase III ACTIVE Study (CTONG1706).
J Thorac Oncol
; 16(9): 1533-1546, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34033974